The practice of medicine is undergoing radical transformation
…towards a more individualized, informed, technological and data-driven care. This process is fueled by emerging technologies coming from various fields, including regenerative medicine, bioelectronics, gene editing, robotics, machine-learning and AI, nanotechnologies, and more, allowing the medical community to engineer human body functions in a more precise way than ever before.
One of the greatest challenges of the 21st century will be to foster these innovations and ensure a rapid and efficient translation from research to market, while allowing as many patients as possible to benefit from them. To do so, a continuous conversation between scientists, entrepreneurs, investors, corporations, governments and the general population is required.
Hello Tomorrow San Francisco’s ambition during the Future of Healthcare session is to highlight disruptive technologies that will shape the future of biomedicine. Our goal is to inspire and encourage the next generation of change-makers, fostering interdisciplinary collaborations, to accelerate innovation in the field. At the same time, we want to take this opportunity to start the conversation about the ethical, legal, political and operational challenges we will have to address in the near future.
Join us on December 15th to hear inspiring talks, learn about the latest technologies in healthcare, new methodologies to improve patient care, and some of the most pressing challenges we have to tackle. Come and meet an amazing diversity of like-minded attendees who will shape the future of healthcare with you!
SPEAKER PREVIEW
- Aubrey de Grey, Biomedical Gerontologist & Chief Science Officer — SENS Research Foundation. The SENS Research Foundation, is a California-based biomedical research charity that performs and funds laboratory research dedicated to combating the aging process.
- Andrew May, Chief Scientific Officer — Caribou Biosciences. He has a background developing technologies and bringing innovative products from concept to commercialization. He is a co-founder of Intellia Therapeutics and before joining Caribou, Andy led development teams in sequencing, single-cell genomics and structural proteomics at Fluidigm Corporation.
- Henry T. Greely, Director, Center for Law and the Biosciences — Stanford University. He is also Professor (by courtesy) of Genetics, Stanford School of Medicine; Chair, Steering Committee of the Center for Biomedical Ethics; and Director, Stanford Program in Neuroscience and Society. Henry T. Greely (BA ’74) specializes in the ethical, legal, and social implications of new biomedical technologies, particularly those related to neuroscience, genetics, or stem cell research.
What: The Future of Healthcare is co-organized by Hello Tomorrow San Francisco and the Office for Science and Technology of the French Embassy in the United States
When: December 15th, 5:00pm to 10:30pm
Where: The Fillmore Heritage Center
To register for the event, go here 👉 https://www.eventbrite.com/e/hello-tomorrow-san-francisco-the-future-of-healthcare-tickets-29079520629
For more information, go here 👉 http://events.hello-tomorrow.org/event/san-francisco/
THANK YOU TO OUR MAIN GLOBAL & LOCAL PARTNERS
BNP PARIBAS & BANK OF THE WEST, Wilson Sonsini Goodrich & Rosati and La French Tech.
To register for the event, go here 👉 https://www.eventbrite.com/e/hello-tomorrow-san-francisco-the-future-of-healthcare-tickets-29079520629
